TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Jiangsu Recbio Technology Co., Ltd. Class H ( (HK:2179) ) has shared an update.
Jiangsu Recbio Technology Co., Ltd. announced that it has received acceptance from the China Securities Regulatory Commission (CSRC) for its application materials related to the issuance of domestic shares. This acceptance marks a significant step forward in the company’s plans, although the issuance is still subject to certain conditions and approvals, creating some uncertainties for stakeholders. The company plans to keep investors informed of further developments in accordance with regulatory requirements.
More about Jiangsu Recbio Technology Co., Ltd. Class H
Jiangsu Recbio Technology Co., Ltd. is a joint stock company based in the People’s Republic of China, operating in the biotechnology sector. The company is focused on the development and issuance of domestic shares, which are integral to its financial and operational strategies.
YTD Price Performance: -7.58%
Average Trading Volume: 67,325
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$4.21B
Find detailed analytics on 2179 stock on TipRanks’ Stock Analysis page.